Actively Recruiting
Impact of Perioperative Sepsis on Inflammatory, Cardiac, Coagulation, and microRNA Profiles in Patients Undergoing Major Abdominal Surgery
Led by Carol Davila University of Medicine and Pharmacy · Updated on 2026-03-02
40
Participants Needed
1
Research Sites
1 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are investigating the effects of perioperative sepsis on inflammation, blood clotting, heart function, and microRNA patterns in adults undergoing major abdominal surgery. This observational study divides 40 patients into septic and non-septic groups based on sepsis criteria and SOFA score changes. The goal is to understand biological and molecular changes linked to sepsis during surgery and explore microRNAs as early indicators of postoperative sepsis. Participants receive standard care without changes, and the study involves collecting clinical data, heart ultrasound exams, and blood samples before surgery and within 24 hours after. Blood tests measure markers of inflammation, coagulation, organ function, and heart injury, while specific microRNAs related to immune response and sepsis are analyzed. Patients are grouped after surgery by sepsis status determined through clinical assessment and SOFA scoring. Throughout the perioperative period, researchers assess differences in biological, heart, and molecular markers between groups. This includes echocardiographic measures of heart performance and levels of various blood markers. The primary focus is on how sepsis affects microRNA profiles. The study lasts from two days before surgery until one day after, with no long-term follow-up. Data collection follows ethical standards and relies on routine clinical assessments and laboratory analyses.
CONDITIONS
Brief Title
Perioperative Sepsis. An Epigenetic Perspective
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Undergoing major abdominal surgery, elective or emergency
- Ability to provide written informed consent
- Availability of biological samples before surgery and within 24 hours after surgery
- Hemodynamically stable before surgery
You will not qualify if you...
- Surgical reintervention within 3 months after the initial procedure
- Multiple surgeries during the same hospital stay
- Active chronic infections such as HIV, viral hepatitis, or tuberculosis
- Autoimmune or systemic inflammatory diseases
- Chronic immunosuppressive therapy or long-term corticosteroid use
- Severe liver failure (Child-Pugh class C)
- End-stage kidney disease requiring dialysis
- Severe heart disease with advanced heart failure (NYHA class III-IV)
- Pregnancy
- Refusal or inability to give informed consent
Research Team
S
Sebastian I Isac, Assist. Prof.
B
Buzatu Cristina
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here